Pancreatic cancer vaccine trialled

Posted on 18 April 2011

A pancreatic cancer vaccine is to be trialled on people with the condition, and if successful it could come to the aid of many people paying for care.

The vaccine is targeted at people who have been diagnosed with pancreatic cancer, and is designed to function by teaching the immune system to destroy cancer cells.

Older people are more likely to suffer from the condition, with 63 per cent of patients diagnosed being over the age of 70.

Patients in hospitals around the UK are participating in the trial, which is being organised by the Royal Liverpool University Hospital.

According to The Times, John Neoptolemos, director of the Liverpool Cancer Research UK Centre, claimed the trial is "pivotal".

"If it's successful, it would make a real difference to the way clinicians behave and patients are treated," he said.

Pancreatic cancer is the fifth most common cause of death from cancer, with approximately 7,800 people in the UK diagnosed with the condition each year.

Posted by Natalie Edwards



News search form